TNF and inflammatory bowel disease: Tumor necrosis factor-alpha (TNF−α) plays a central role in the inflammatory cascade, and anti-TNF−α therapies, such as infliximab (IFX) and adalimumab (ADA), have revolutionized the management of IBD [1].